BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12904141)

  • 21. Tamoxifen and secondary tumours. An update.
    Wilking N; Isaksson E; von Schoultz E
    Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of tamoxifen in the treatment and prevention of breast cancer.
    Jordan VC
    Curr Probl Cancer; 1992; 16(3):129-76. PubMed ID: 1582240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen for the prevention of breast cancer.
    Greenspan EM
    Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of breast cancer in high-risk women.
    Kardinal CG; Veith R
    J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs.
    Yang G; Nowsheen S; Aziz K; Georgakilas AG
    Pharmacol Ther; 2013 Sep; 139(3):392-404. PubMed ID: 23711794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is tamoxifen a genotoxic carcinogen in women?
    Brown K
    Mutagenesis; 2009 Sep; 24(5):391-404. PubMed ID: 19505894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tamoxifen and breast cancer: is everything known already?].
    Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
    Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective estrogen-receptor modulators in 2001.
    O'Regan RM; Gradishar WJ
    Oncology (Williston Park); 2001 Sep; 15(9):1177-85, 1189-90; discussion 1190-4. PubMed ID: 11589065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen in cancer therapy: minireview.
    Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
    Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk-benefit profiles of women using tamoxifen for chemoprevention.
    Nichols HB; DeRoo LA; Scharf DR; Sandler DP
    J Natl Cancer Inst; 2015 Jan; 107(1):354. PubMed ID: 25475563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention for high-risk women: tamoxifen and beyond.
    Fabian CJ; Kimler BF
    Breast J; 2001; 7(5):311-20. PubMed ID: 11906441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks and benefits of tamoxifen therapy.
    Assikis VJ; Jordan VC
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):21-3. PubMed ID: 9065923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer prevention.
    Powles TJ
    Oncologist; 2002; 7(1):60-4. PubMed ID: 11854547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there a basis for prevention of breast cancer with drugs?].
    Klemetsdal B
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1493-5. PubMed ID: 9198929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Powles TJ
    J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemoprevention of breast cancer.
    Brown PH; Lippman SM
    Breast Cancer Res Treat; 2000 Jul; 62(1):1-17. PubMed ID: 10989982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
    Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
    Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant tamoxifen versus tamoxifen plus CMF in the treatment of early breast cancer in Greece. Fifteen-year results of a randomised prospective trial and the potential risks of the antioestrogen.
    Vorgias G; Koukouras D; Tzoracoeleftherakis E; Paleogianni V; Androulakis J
    Anticancer Res; 2000; 20(5C):3849-54. PubMed ID: 11268466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of tamoxifen treatment on the endometrium.
    Daniel Y; Inbar M; Bar-Am A; Peyser MR; Lessing JB
    Fertil Steril; 1996 Jun; 65(6):1083-9. PubMed ID: 8641477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.